West Pharma Shares Drop Following Cyberattack Disclosure

Deep News05-12

On May 12, the stock of medical device manufacturer West Pharmaceutical Services fell 3.6% to $310. The company stated on Monday evening that it had experienced a significant cybersecurity incident, during which an unauthorized third party stole some data and encrypted portions of its systems. West Pharma discovered the attack on May 4 and promptly took its systems offline, notified law enforcement, and engaged external cybersecurity specialists. The incident caused a temporary disruption to global operations. While core systems have been restored, and shipping, production, and receiving activities have resumed at some facilities, a full timeline for complete recovery is not yet available. The company noted that the financial impact of the event has not yet been determined, as the investigation and system restoration efforts are ongoing. Other medical device firms have faced similar issues recently. Stryker and Intuitive Surgical encountered cybersecurity events in March, while Medtronic disclosed an incident in April. Including today's trading session, West Pharmaceutical Services' stock has gained 13% year-to-date.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment